News

Published on 29 Feb 2024 on Insider Monkey via Yahoo Finance

Vaxcyte, Inc. (NASDAQ:PCVX) Q4 2023 Earnings Call Transcript


Article preview image

Vaxcyte, Inc. (NASDAQ:PCVX) Q4 2023 Earnings Call Transcript February 28, 2024

Vaxcyte, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).

Operator: Good afternoon, everyone. My name is Bo and I will be your conference operator today. At this time, I would like to welcome everyone to the Vaxcyte Fourth Quarter and Full-Year 2023 Financial Results Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer period. [Operator Instructions] And just a reminder, today's call is being recorded. Now at this time, I will turn things over to Mr. Andrew Guggenhime, President and Chief Financial Officer of Vaxcyte. Please go ahead, sir.

NASDAQ.PCVX price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Is Vaxcyte, Inc. (PCVX) the Best Performing Biotech Stock in 2024?

We recently compiled a list of the 10 Best Performing Biotech Stocks in 2024. In this article, we...

Insider Monkey · via Yahoo Finance 23 Dec 2024

What Makes Vaxcyte (PCVX) An Investment Bet?

TimesSquare Capital Management, an equity investment management company, released its “U.S. Small...

Insider Monkey · via Yahoo Finance 9 Dec 2024

Is it Wise to Retain Alexandria Stock in Your Portfolio Now?

However, the company’s significant development pipeline increases the risks related to cost overr...

Zacks · via Yahoo Finance 28 Nov 2024

Vaxcyte (PCVX) Surged On Positive Phase 2 Data For Its Drug

Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap...

Insider Monkey · via Yahoo Finance 27 Nov 2024

Decoding Vaxcyte Inc (PCVX): A Strategic SWOT Insight

Exploring Vaxcyte Inc's robust research and development investments and its implications for futu...

GuruFocus.com · via Yahoo Finance 6 Nov 2024

Should You Consider Investing in Vaxcyte (PCVX)?

Baron Funds, an investment management company, released its “Baron Health Care Fund” third quarte...

Insider Monkey · via Yahoo Finance 1 Nov 2024

Vaxcyte, Inc. (PCVX): Among Hedge Funds’ Top Biotech Stock Picks

We recently compiled a list of the 10 Largest Biotech Hedge Funds and Their Top Stock Picks. In t...

Insider Monkey · via Yahoo Finance 22 Sep 2024

Vaxcyte, Inc. (NASDAQ:PCVX) Q4 2023 Earnings Call Transcript

Vaxcyte, Inc. (NASDAQ:PCVX) Q4 2023 Earnings Call Transcript February 28, 2024 Vaxcyte, Inc. isn’...

Insider Monkey via Yahoo Finance 29 Feb 2024

Vaxcyte, Inc. (PCVX) Is Up 2.14% in One Week: What You Should Know

Momentum investing is all about the idea of following a stock's recent trend, which can be in eit...

Zacks via Yahoo Finance 28 Feb 2024

Vaxcyte, Inc. (NASDAQ:PCVX) Q4 2023 Earnings Call Transcript

Vaxcyte, Inc. (NASDAQ:PCVX) Q4 2023 Earnings Call Transcript February 28, 2024 Vaxcyte, Inc.  isn...

Insider Monkey via Yahoo Finance 28 Feb 2024